Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 1435 Records) |
Query Trace: Ovarian Neoplasms and BRCA1[original query] |
---|
Comparing Prognosis for BRCA1, BRCA2, and Non-BRCA Breast Cancer. Cancers 2023 12 15 (23): . Pedro Antunes Meireles, Sofia Fragoso, Teresa Duarte, Sidónia Santos, Catarina Bexiga, Priscila Nejo, Ana Luís, Beatriz Mira, Isália Miguel, Paula Rodrigues, Fátima V |
A Novel Germline Mutation of BRCA1 and Integrated Analysis With Somatic Mutation in a Chinese Multi-Cancer Family. The oncologist 2023 12 . Xiling Yang, Li Shang, Liren Yang, Landi Sun, Xiaoqian Tuo, Sijia Ma, Le Zhao, Xu Li, Wenfang Ya |
Cerebellar metastasis of ovarian cancer: a case report. Journal of medical case reports 2023 12 17 (1): 553. Eleonora Cabitza, Marta Pirola, Cinzia Baldessari, Giuditta Bernardelli, Elena Zunarelli, Stefania Pipitone, Maria Giuseppa Vitale, Cecilia Nasso, Eleonora Molinaro, Marco Oltrecolli, Elisa D'Agostino, Vincenzo Dario Mandato, Andrea Palicelli, Massimo Dominici, Roberto Sabbati |
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival. Gynecologic oncology 2023 12 180 35-43. Ryan M Kahn, Pier Selenica, Thomas Boerner, Kara Long Roche, Yonghong Xiao, Tiffany Y Sia, Anna Maio, Yelena Kemel, Margaret Sheehan, Erin Salo-Mullen, Kelsey E Breen, Qin Zhou, Alexia Iasonos, Rachel N Grisham, Roisin E O'Cearbhaill, Dennis S Chi, Michael F Berger, Ritika Kundra, Nikolaus Schultz, Lora H Ellenson, Zsofia K Stadler, Kenneth Offit, Diana Mandelker, Carol Aghajanian, Dmitriy Zamarin, Paul Sabbatini, Britta Weigelt, Ying L L |
Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer. Gynecologic oncology 2023 12 181 33-39. Ji Hyun Kim, Se Ik Kim, Eun Young Park, Eun Taeg Kim, Hyesu Kim, Sangeon Kim, Sang-Yoon Park, Myong Cheol L |
Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia. Advances in laboratory medicine 2023 12 4 (3): 279-287. Laura Rosado-Jiménez, Younes Mestre-Terkemani, Ángeles García-Aliaga, Miguel Marín-Vera, José Antonio Macías-Cerrolaza, María Desamparados Sarabia-Meseguer, María Rosario García-Hernández, Marta Zafra-Poves, Pilar Sánchez-Henarejos, Francisco Ayala de la Peña, José Luis Alonso-Romero, José Antonio Noguera-Velasco, Francisco Ruiz-Espe |
Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer. Scientific reports 2023 12 13 (1): 21884. Nikki L Burdett, Madelynne O Willis, Ahwan Pandey, Sian Fereday, , Anna DeFazio, David D L Bowtell, Elizabeth L Christ |
Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer research 2023 12 . Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun L |
Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial. Oncogene 2023 11 . Celine Callens, Manuel Rodrigues, Adrien Briaux, Eleonore Frouin, Alexandre Eeckhoutte, Eric Pujade-Lauraine, Victor Renault, Dominique Stoppa-Lyonnet, Ivan Bieche, Guillaume Bataillon, Lucie Karayan-Tapon, Tristan Rochelle, Florian Heitz, Sabrina Chiara Cecere, Maria Jesús Rubio Pérez, Christoph Grimm, Trine Jakobi Nøttrup, Nicoletta Colombo, Ignace Vergote, Kan Yonemori, Isabelle Ray-Coquard, Marc-Henri Stern, Tatiana Popo |
Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid. Molecular cancer 2023 11 22 (1): 178. Cyril Roussel-Simonin, Felix Blanc-Durand, Roseline Tang, Damien Vasseur, Audrey Le Formal, Laure Chardin, Elisa Yaniz, Sébastien Gouy, Amandine Maulard, Stéphanie Scherier, Claire Sanson, Ludovic Lacroix, Sophie Cotteret, Lea Mauny, François Zaccarini, Etienne Rouleau, Alexandra Lea |
[BRCA2 Mutation Profile in a Proband with Hereditary Breast and Ovarian Cancer-Two Germline Pathogenic Variants Aligned in the Cis Position]. Gan to kagaku ryoho. Cancer & chemotherapy 2023 11 50 (10): 1089-1091. Seigo Yukisawa, Toshiyuki Kakinuma, Junko Yotsumoto, Kentaro Kawakami, Junji Furukawa, Hiroharu Shinoza |
Concurrent RB1 loss and BRCA -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma. medRxiv : the preprint server for health sciences 2023 11 . Flurina A M Saner, Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A Zwimpfer, Nicola S Meagher, Sian Fereday, Laura Twomey, Kathleen I Pishas, Therese Hoang, Adelyn Bolithon, Nadia Traficante, Kathryn Alsop, Elizabeth L Christie, Eun-Young Kang, Gregg S Nelson, Prafull Ghatage, Cheng-Han Lee, Marjorie J Riggan, Jennifer Alsop, Matthias W Beckmann, Jessica Boros, Alison H Brand, Angela Brooks-Wilson, Michael E Carney, Penny Coulson, Madeleine Courtney-Brooks, Kara L Cushing-Haugen, Cezary Cybulski, Mona A El-Bahrawy, Esther Elishaev, Ramona Erber, Simon A Gayther, Aleksandra Gentry-Maharaj, C Blake Gilks, Paul R Harnett, Holly R Harris, Arndt Hartmann, Alexander Hein, Joy Hendley, Aocs Group, Brenda Y Hernandez, Anna Jakubowska, Mercedes Jimenez-Linan, Michael E Jones, Scott H Kaufmann, Catherine J Kennedy, Tomasz Kluz, Jennifer M Koziak, Björg Kristjansdottir, Nhu D Le, Marcin Lener, Jenny Lester, Jan Lubi?ski, Constantina Mateoiu, Sandra Orsulic, Matthias Ruebner, Minouk J Schoemaker, Mitul Shah, Raghwa Sharma, Mark E Sherman, Yurii B Shvetsov, Naveena Singh, T Rinda Soong, Helen Steed, Paniti Sukumvanich, Aline Talhouk, Sarah E Taylor, Robert A Vierkant, Chen Wang, Martin Widschwendter, Lynne R Wilkens, Stacey J Winham, Michael S Anglesio, Andrew Berchuck, James D Brenton, Ian Campbell, Linda S Cook, Jennifer A Doherty, Peter A Fasching, Renée T Fortner, Marc T Goodman, Jacek Gronwald, David G Huntsman, Beth Y Karlan, Linda E Kelemen, Usha Menon, Francesmary Modugno, Paul D P Pharoah, Joellen M Schildkraut, Karin Sundfeldt, Anthony J Swerdlow, Ellen L Goode, Anna DeFazio, Martin Köbel, Susan J Ramus, David D L Bowtell, Dale W Gars |
Detection of clinically important BRCA gene mutations in ovarian cancer patients using next generation sequencing analysis. American journal of cancer research 2023 11 13 (10): 5005-5020. Yiping Zhang, Akbar Ali, Jun X |
The BRCA1 c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times. International journal of molecular sciences 2023 11 24 (21): . Paolo Aretini, Silvano Presciuttini, Aldo Pastore, Alvaro Galli, Sara Panepinto, Mariella Tancredi, Matteo Ghilli, Chiara Guglielmi, Diletta Sidoti, Caterina Congregati, Maria Adelaide Cali |
Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience. Hereditary cancer in clinical practice 2023 11 21 (1): 23. Aya Tanaka, Megumi Matsumoto, Mami Takao, Shoko Miura, Yuri Hasegawa, Ryota Otsubo, Hiroko Hayashi, Ichiro Isomoto, Kiyonori Miura, Takeshi Nagaya |
A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer. Breast care (Basel, Switzerland) 2023 10 18 (5): 412-416. Paulina Gebhart, Yen Tan, Daniela Muhr, Christina Stein, Christian Sing |
Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapse. Journal of ovarian research 2023 10 16 (1): 209. Yana Ma, Jiale Liu, Ning Li, Hualei Bu, Yongwen Huang, Chengjuan Jin, Hao Wen, Shuai Feng, Hui Zhang, Xiaorong Yang, Beihua Kong, Lingying Wu, Kun So |
Ethnicity-specific BRCA1, BRCA2, PALB2, and ATM pathogenic alleles in breast and ovarian cancer patients from the North Caucasus. Breast cancer research and treatment 2023 10 . Anna P Sokolenko, Elvina Kh Bakaeva, Aigul R Venina, Ekaterina Sh Kuligina, Alexandr A Romanko, Svetlana N Aleksakhina, Yana V Belysheva, Evgeniya V Belogubova, Ilya A Stepanov, Olga A Zaitseva, Olga S Yatsuk, Alexandr V Togo, Zaur M Khamgokov, Azinat O Kadyrova, Albert Sh Pirmagomedov, Marina B Bolieva, Alexandr A Epkhiev, Aslan K Tsutsaev, Madina D Chakhieva, Khalimat M Khabrieva, Idris M Khabriev, Mirza A Murachuev, Bella N Buttaeva, Liliya S Baboshkina, Fatima I Bayramkulova, Islam R Katchiev, Lina Kh Alieva, Grigory A Raskin, Sergey V Orlov, Zarema K Khachmamuk, Karine R Levonyan, Dariya M Gichko, Dmitriy V Kirtbaya, Alexey M Degtyariov, Luisa V Sultanova, Hedi S Musayeva, Alexey M Belyaev, Evgeny N Imyanit |
Development and validation of a sensitive LC-MS/MS method for the assay of four PARP inhibitors in human plasma and its application in ovarian cancer patients. Journal of pharmaceutical and biomedical analysis 2023 10 237 115758. Yuru Wei, Haixi Liang, Shu Liu, Shaoxing Guan, Kaiyun Ma, Yanping Guan, Youhao Chen, Min Huang, Xueding Wang, Chunyan L |
Variants in BRCA1/2 in a hospital-based cohort in Chile and national literature review. Ecancermedicalscience 2024 4 18 1683. Fernanda J Martin, Isabel M Saffie, Mabel A Hurtado, Diana Avila-Jaque, Rodrigo A Lagos, Carolina A Selman, Jonathan Z Huserman, Valentina A Castillo, Badir J Chahu |
Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System. BMC cancer 2024 4 24 (1): 499. Caroline de Oliveira Ferreira, Vandré Cabral Gomes Carneiro, Carolline Araujo Mar |
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer. medRxiv : the preprint server for health sciences 2024 4 . Ed M Dicks, Jonthan P Tyrer, Suzana Ezquina, Michelle Jones, John Baierl, Pei-Chen Peng, Michael Diaz, Ellen Goode, Stacey J Winham, Thilo Dörk, Toon Van Gorp, Ana De Fazio, David Bowtell, Kunle Odunsi, Kirsten Moysich, Marina Pavanello, Ian Campbell, James D Brenton, Susan J Ramus, Simon A Gayther, Paul D P Pharo |
A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants. Clinical laboratory 2024 4 70 (4): . Jin Ju Kim, Dong Ja Kim, Eon Jeong Nam, Kyung Eun Song, Ji Yeon Ham, Yu Kyung Kim, Nan Young L |
PRDM1 rs2185379, unlike BRCA1, is not a prognostic marker in patients with advanced ovarian cancer. Cancer biomarkers : section A of Disease markers 2024 4 . Klara Horackova, Michal Vocka, Sarka Lopatova, Petra Zemankova, Zdenek Kleibl, Jana Soukupo |
Risk factors for ovarian cancer by BRCA status: a collaborative case-only analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2024 2 . Kate Gersekowski, Renhua Na, Kathryn Alsop, Rachel Delahunty, Ellen L Goode, Julie M Cunningham, Stacey J Winham, Paul D P Pharoah, Honglin Song, Penelope M We |
Rare copy-number variants as modulators of common disease susceptibility. Genome medicine 2024 1 16 (1): 5. Chiara Auwerx, Maarja Jõeloo, Marie C Sadler, Nicolò Tesio, Sven Ojavee, Charlie J Clark, Reedik Mägi, , Alexandre Reymond, Zoltán Kutal |
Optical Genome Mapping Reveals the Landscape of Structural Variations and Their Clinical Significance in HBOC-Related Breast Cancer. Frontiers in bioscience (Landmark edition) 2024 1 29 (1): 2. Yanan Cheng, Li Dong, Dechao Bu, Lei Han, Yi Zhao, Juntian Liu, Xiaojing Guo, Hanli Xu, Jinpu |
PARPis response and outcome of ovarian cancer patients with BRCA1/2 germline mutation and a history of breast cancer. Journal of gynecologic oncology 2024 1 . Hua Yuan, Lin Xiu, Ning Li, Yifan Li, Lingying Wu, Hongwen Y |
Association Between Germline BRCA1/2 Gene Variants and Clinicopathological Features of Ovarian Cancer. International journal of general medicine 2024 1 17 75-84. Yu Luo, Ru Pan, Hui Rao, Xing Chen, Haikun Ya |
Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing. Pathology, research and practice 2024 1 254 155075. Seref Bugra Tuncer, Betul Celik, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Busra Kurt Gültaslar, Demet Akdeniz Odemis, Mukaddes Avsar, Fatma Sen, P?nar Mualla Saip, Hulya Yazi |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: